Which topical Anti-herpes agent has better bioavailability and efficacy?

Which topical Anti-herpes agent has better bioavailability and efficacy?

• A. Trifluridine (Viroptic)
• B. Ganciclovir (Zirgan)
• C. Acyclovir (Zovirax)
• D. Penciclovir (Denavir)

Answer: (B)

The key idea is how well the drug reaches and stays active at the site of infection in the eye. Ganciclovir formulated as an ophthalmic gel achieves higher corneal bioavailability and sustained concentrations in the infected tissue than the other topical agents. This translates into more effective viral suppression and better clinical response for herpetic keratitis, with a more favorable tolerability profile compared with agents that are more irritating to the ocular surface. Acyclovir, while antiviral, has poorer corneal penetration in topical form, limiting its efficacy. Trifluridine is potent but tends to cause more local toxicity and requires frequent dosing, reducing practicality and tolerance. Penciclovir, though active, does not provide tissue levels at least as favorable as ganciclovir in the ocular setting.

The key idea is how well the drug reaches and stays active at the site of infection in the eye. Ganciclovir formulated as an ophthalmic gel achieves higher corneal bioavailability and sustained concentrations in the infected tissue than the other topical agents. This translates into more effective viral suppression and better clinical response for herpetic keratitis, with a more favorable tolerability profile compared with agents that are more irritating to the ocular surface. Acyclovir, while antiviral, has poorer corneal penetration in topical form, limiting its efficacy. Trifluridine is potent but tends to cause more local toxicity and requires frequent dosing, reducing practicality and tolerance. Penciclovir, though active, does not provide tissue levels at least as favorable as ganciclovir in the ocular setting.